Tag: Tislelizumab approval expands
Tislelizumab approval expands in China and EU for cancer treatment
Tislelizumab, a humanized monoclonal antibody, has been making strides in the treatment of various forms of cancer. As of September 15, 2023, this anti-cancer medication...
